Palleon Pharmaceuticals appoints David Johnson to its Board of Directors

https://palleonpharma.com/press-releases/palleon-pharmaceuticals-appoints-david-johnson-to-its-board-of-directors/

Previous
Previous

BioTheryX receives IND clearance from FDA to proceed with Ph1 Study of BTX-1188

Next
Next

BioTheryX appoints Philippe Drouet as CEO